These effectors include vascular endothelial cells, macrophages, neutrophils, lymphocytes, and other immune-related cell types
As coverage expands and evidence grows, expect oral GLP1 agents to take a more central role in both primary care and specialty settings
From the telehealth and overprescribing boom, to the rise in questionable compounding and advertising practices, its safe to say that we may need to take a more serious approach to our production this time (dont worry, the production team will still make it fun)
The titration process is designed to balance therapeutic effectiveness with tolerability
Cardiovascular benefits have been demonstrated in clinical trials for specific GLP-1 receptor agonists, with liraglutide, semaglutide, and dulaglutide showing reductions in major adverse cardiovascular events in patients with established cardiovascular disease or high cardiovascular risk
The decision to prescribe Saxenda or Wegovy is at the discretion of your healthcare provider
